Griffin, Donald R.
Weaver, Westbrook M.
Scumpia, Philip O.
Di Carlo, Dino
Segura, Tatiana
Article History
Received: 20 November 2014
Accepted: 15 April 2015
First Online: 1 June 2015
Competing interests
: The authors have a financial interest in Tempo Therapeutics, which aims to commercialize MAP technology.